| F11 |
F11: Coagulation factor XI precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
15.050 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
PRTN3 |
PRTN3, MBN: Myeloblastin precursor |
15.050 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
F5 |
F5: Coagulation factor V precursor |
15.050 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
ELA2 |
ELA2: Leukocyte elastase precursor |
15.050 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
15.050 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
15.050 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
F11 |
F11: Coagulation factor XI precursor |
15.050 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SPOCK1 |
SPOCK1, SPOCK, TIC1, TICN1: Testican-1 precursor |
15.050 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
15.050 |
Evidence |
|
| APCS |
APCS, PTX2: Serum amyloid P-component precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
15.050 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
CD46 |
IPI00012035 |
15.050 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
15.050 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
F5 |
F5: Coagulation factor V precursor |
15.050 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
15.050 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
ELA2 |
ELA2: Leukocyte elastase precursor |
15.050 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
15.050 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
CFHR1 |
CFHR1, CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, HFL1, HFL2: Complement factor H-relate |
15.050 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
SPINK2 |
SPINK2: Serine protease inhibitor Kazal-type 2 precursor |
15.050 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
EPOR |
EPOR: Erythropoietin receptor precursor |
15.050 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
GHR |
GHR: Growth hormone receptor precursor |
15.050 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
15.050 |
Evidence |
|
| SLITRK5 |
SLITRK5, KIAA0918, LRRC11: SLIT and NTRK-like protein 5 precursor |
EDA |
IPI00023765 |
15.050 |
Evidence |
|
| TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
15.050 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
15.050 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
15.050 |
Evidence |
|